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Background: Several studies point to a correlation between obesity and the severity of depressive and anxiety
symptoms in children and adults, but there are still some controversial points about this association. The aim of this
study is to investigate the relationship between body composition and the severity of anxiety/depressive symptoms
in overweight and obese individuals with Metabolic Syndrome (MS).
Methods: Fifty patients, 18–50 years old, overweight or obese and with the diagnosis of MS based on the
International Diabetes Federation (IDF) criteria were selected for this study. Body composition was evaluated using
Dual Energy X-ray Absorptiometry (DXA). Depressive symptoms were evaluated using the Hospital Anxiety and
Depression Scale (HADS-Depression) and the Beck Depression Inventory (BDI). Anxiety symptoms were evaluated
using HADS-Anxiety.
Results: No correlation was found between depressive symptoms (HADS-Depression or BDI) and Body Mass Index
(BMI) (r = 0.01; p = 0.94 and r = −0.12, p = 0.38; respectively), Waist Circumference (WC) (r = −0.06, p = 0.67 and
r = −0.22, p = 0.12; respectively), and Waist-to-Hip Ratio (WHR) (r = −0.12, p = 0.40 and r = −0.17, p = 0.23;
respectively). Additionally, no correlation was found among anxiety symptoms (HADS-Anxiety) and BMI (r = −0.15,
p = 0.27), and WHR (r = −0.17, p = 0.24). In contrast, a significant correlation was found between percentage of total
fat (DXA) and HADS-Depression (r = 0.34, p = 0.019) and HADS-Anxiety (r = 0.30, p = 0.039). Additionally, an inverse
and strong correlation was found between lean mass (in grams) and HADS-Depression (r = −0.42, p = 0.004), HADS
anxiety (r = −0.57, p < 0.0001), and BDI (r = −0.44, p = 0.026).
Conclusions: In individuals with MS, the percentage of body fat, and not central fat, BMI, WC, or WHR, was
associated with an increased severity of anxiety and depressive symptoms. In contrast, total lean mass was strongly
associated with fewer anxiety/depressive symptoms, suggesting that body composition might be related to
psychiatric comorbidity in overweight individuals with MS.
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The prevalence of obesity, depression, and anxiety is
growing in the industrialized world [1]. Currently, there
is an epidemic of obesity in children and adults resulting
mainly from a sedentary lifestyle and overeating. Meta-
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pose tissue in the abdominal cavity (known as visceral
obesity) leads to the development of impaired glucose
metabolism, hypertension, and dyslipidemia see ref. [2]
for review. The combination of these comorbidities in-
creases the risk of complications, including psycho-
pathological conditions [3-5].
Depression and anxiety are two of the most common
psychiatric disorders. Several studies point to a correlation
between obesity and the severity of depressive and anxietyl Ltd. This is an Open Access article distributed under the terms of the Creative
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but there are still some controversial points about this
association. While some studies suggest that increased
weight per se is a major determinant of psychiatric
symptoms [5,6], others suggest that fat distribution may
be a stronger determinant of this relationship [7,8]. In
contrast, it is also plausible to speculate that psychiatric
disturbances may interfere with body fat distribution,
especially by favoring visceral fat deposits. To the best
of our knowledge, most of the studies have used only
anthropometric variables in their analysis [5-8]. Dual
energy X-ray absorptiometry (DXA) is based on the
relative attenuation of two different energy X-rays and
produces a three-component model of body compos-
ition comprising fat, bone mineral and lean tissue. Scans
are relatively quick, involve minimal radiation exposure
and also allows for regional analysis and body fat
distribution [9]. We are aware of only one previous pub-
lication utilizing DXA to evaluate body composition, to
test its relationship with the severity of psychiatric
symptoms in individuals with MS, and this is the focus
of the present study [10]. We therefore hypothesize that
body fat and lean mass evaluated separately by DXA
could better reflect the influence the association be-
tween obesity and depression/anxiety symptoms than
anthropometric methods.Participants
We evaluated a consecutive sample of fifty patients will-
ing to lose weight who seek treatment for obesity and
MS in our Institution and fulfilled eligibility criteria to
participate in a study with intragastric balloon (regis-
tered at ClinicalTrials.gov; identifier: NCT01598233).
The protocol was approved by the Ethics Committee of
the State Institute of Diabetes and Endocrinology of Rio
de Janeiro, where the patients were recruited, and written
informed consent was obtained from each participant. In-
cluding criteria: age between 18 to 50 years old, be over-
weight or obese (Body Mass Index [BMI] ≥ 25 kg/m2) and
have Metabolic Syndrome (MS) based on International
Diabetes Federation (IDF) criteria [11].
Exclusion criteria were as follows: diabetes mellitus
type 1 or 2, pregnancy or desire to become pregnant in
the next six months, alcoholism, advanced liver disease,
end stage renal disease, current or prior Coronary Artery
Disease (defined as prior Myocardial Infarction, Stable
or Unstable Angina, or coronary revascularization),
current or prior cerebrovascular disease (defined as
prior Ischemic Stroke, Transitory Ischemic Attack or ca-
rotid revascularization), history of psychiatric disorder,
current use of antidepressants or other psychiatric medi-
cation, use of anti-obesity medications and weight loss
treatment in the last 6 months. Patients were examined byan endocrinologist and provided a detailed medical history
at baseline evaluation.
Anthropometrical measures
The following anthropometrical data were registered:
body weight (kg), height (m), waist circumference (WC)
and waist/hip ratio (WHR). BMI was calculated as weight
divided by the square of height (kg/m2). Waist circumfer-
ence (cm) was determined at the midpoint between the
lowest rib and the iliac crest. WHR was defined as the ra-
tio of waist girth to the largest circumference of the hips,
measured at the trochanter major.
Evaluation of body composition
Body composition was evaluated by dual energy X-ray
absorptiometry [DXA] using a Prodigy-GE densitometer
(GE Healthcare, Inc., Madison, WI, USA), and included
measurement of body fat content (%), fat distribution
and lean mass (grams). The truncal pattern of fat distri-
bution was characterized by preferential fat deposition
in the trunk, the android pattern by fat deposition in the
abdomen, and the gynoid type by fat deposition in the
gluteal–femoral area [12]. Fat Mass Ratio (FMR) was the
ratio of the percentage of the trunk fat mass to the per-
centage of the lower limb fat mass [13].
Anxiety and depressive symptoms
Anxiety and depression symptoms were assessed by the
Hospitalar Anxiety and Depression Scale (HADS), a self-
report measurement to assess anxiety and depressive
symptoms during the previous week. The items exclude
somatic symptoms, avoiding overlap between somatic ill-
ness and mood disorders. It includes seven statements on
each disorder (HADS-Anxiety and HADS-Depression),
and each response consists of a four-point rating scale; a
higher score indicates a worse condition [14]. The Beck
Depression Inventory (BDI) was also used to measure
severity of depression. The instrument comprises 21
questions, each one with four answer options. The total
score is the sum of the scores obtained for each individual
item [15].
Statistical analysis
The statistical analysis was performed with GraphPad
InStat 3.00 for Windows 95 (GraphPad Software, San
Diego, CA, USA). Pearson’s correlation coefficient or
Spearman’s correlation coefficient was used to determine
the correlations between the anthropometric indicators
of weight excess, including body composition, and psy-
chiatric symptoms. Multivariate Linear Regression was
used to investigate the impact of age and gender in the
severity of anxiety and depressive symptoms. The level
of statistical significance was set at 5% (p ≤ 0.05).
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Fifty individuals (40 women), aged from 22 to 48 years old
(mean 34.6 ± 7.1), with MS were evaluated. BMI ranged
from 29.2 to 53.7 kg/m2 (mean 40.0 ± 6.3) and WC from
91 to 147.5 cm (mean 115.4 ± 12.8). The mean value for
HADS-Anxiety was 8.4 ± 3.9, for HADS-Depression was
7.1 ± 3.3, and for BDI was 15.0 ± 7.7.
Correlation analysis was used to evaluate the relation-
ship among anthropometric variables (i.e. BMI and WC)
and body composition (Table 1). As expected, BMI pre-
sented a significant correlation with body fat. However, a
significant correlation was also found between BMI and
lean mass. On the other hand, a significant correlation
was found only between WC and android fat. Unexpect-
edly, very significant correlations were between WC and
lean mass.
No correlation was found between depressive symp-
toms (HADS depression) and BMI, WC and WHR. Also,
no correlation was found among anxiety symptoms
(HADS anxiety) and BMI and WHR. A negative correl-
ation was found between anxiety symptoms and WC.
Very similar results were also yielded with BDI. No cor-
relation was found between BDI and BMI, WC and
WHR. In contrast, several parameters of body compos-
ition measured by DXA were significantly associated
with psychiatric symptoms, especially anxiety. These
data are shown in Table 2.
Linear regression was used to investigate whether age
and gender would interfere with the association among
Total Body fat, Total Lean Mass and anxiety/depressive
symptoms. The inverse correlation between Total Lean
Mass and HADS-Anxiety remained significant even after
adjustment for age and gender (p = 0.019). Similar results
were yielded with Total Lean Mass and HADS-Depression,
although with borderline significance (p = 0.06).
Discussion
The relationship between obesity and mood disorders
(especially depression) has been extensively studied inTable 1 Correlation between anthropometric variables
and body composition in obese and overweight
individuals with metabolic syndrome
BMI (kg/m2) WC (cm)
R P r p
Total fat (%) 0.52 0.0002 0.18 0.23
Android fat (%) 0.48 0.0008 0.34 0.021
Gynoid fat (%) 0.43 0.0027 0.10 0.48
Trunk fat (%) 0.38 0.0086 0.16 0.28
Total lean mass (g) 0.38 0.0082 0.65 <0.001
Gynoid lean mass (g) 0.30 0.039 0.51 <0.003
Android lean mass (g) 0.44 0.0024 0.65 <0.001
BMI = Body Mass Index; WC =Waist Circumference.recent years, and a bidirectional association seems un-
equivocal [4]. However, most of the studies have only
evaluated indirect measurements of adiposity, such as
BMI and WC [5-8]. These anthropometric variables, al-
though largely used in clinical practice, may neither indi-
cate the total body fat nor differentiate lean from fat
mass. In the present study, we used DXA to determine
total lean mass and the percentage of body fat and cor-
related these parameters with depressive and anxiety
symptoms in overweight individuals with MS. Our most
relevant results were the following: i – a significant cor-
relation was found between BMI and both lean and fat
mass; ii – overall, no correlation was found among an-
thropometric variables and psychiatric symptoms; iii -
there was a direct correlation between the percentage of
body fat and the severity of depressive and anxiety symp-
toms; and iii – there was a strong and inverse correlation
between lean mass and specific psychiatric symptoms.
The relationship between total fat and psychiatric symp-
toms in overweight individuals is of great relevance for
clinical practice. Recently, a few studies have demonstrated
that depressive symptoms may be an important predictor
of abdominal obesity [10,16]. The most acceptable hypoth-
esis for this relationship involves the hypothalamus-
pituitary-adrenal (HPA) axis. As a chronic stressor, mood
disorders may change cortisol secretion by stimulation of
the HPA axis. This elevation in serum cortisol can increase
abdominal fat deposition, promoting glucose intolerance
and hypertension [16,17]. However, the lack of correlation
between depression and visceral fat has been demonstrated
in the elderly [18]. In contrast, we could demonstrate that
the total amount of body fat may be more related to psy-
chiatric symptoms than central fat per se. Because only pa-
tients with MS were included in the present study, we may
speculate that we have already included patients with in-
creased visceral fat.
One unexpected finding was the inverse relationship
found between anxiety symptoms and WC. We could
not find a reasonable explanation for this novel finding
and we may not exclude that this may be only a false
positive result. Further studies are necessary to replicate
and clarify this issue.
The existence of a strong and inverse correlation be-
tween lean mass and anxiety/depressive symptoms in
overweight individuals with MS, even more significant
than the correlation between body fat and these same
symptoms, is a novel finding with major implications.
Body Mass Index is the anthropometric variable frequently
used in clinical research to investigate the relationship be-
tween weight excess and psychopathology. However, major
limitations of BMI include that it cannot differentiate lean
from fat mass excess [19] and also that there may exist im-
portant ethnic-specific differences with this parameter [20].
These limitations may be of particular relevance in men,
Table 2 Correlation between body composition and anxiety/depressive symptoms in overweight and obese individuals
with metabolic syndrome
Parameters HADS-Anxiety HADS-Depression BDI
r p r p r p
BMI (kg/m2) −0.15 0.27 0.01 0.94 −0.12 0.38
Waist circumference (cm) −0.29 0.038 −0.06 0.67 −0.22 0.12
Waist-to-hip ratio −0.17 0.24 −0.12 0.40 −0.17 0.23
Total fat (%) 0.30 0.039 0.34 0.019 0.22 0.13
Android fat (%) 0.15 0.32 0.25 0.087 0.18 0.22
Gynoid fat (%) 0.26 0.083 0.32 0.029 0.21 0.16
Trunk fat (%) 0.26 0.078 0.32 0.031 0.24 0.11
FMR −0.27 0.068 −0.27 0.065 −0.11 0.45
Total lean mass (g) −0.57 <0.0001 −0.42 0.004 −0.44 0.027
Gynoid lean mass (g) −0.50 <0.0001 −0.33 0.024 −0.34 0.22
Android lean mass (g) −0.47 <0.0001 −0.37 0.010 −0.44 0.026
BMI = Body Mass Index; g = grams; FMR = Fat Mass ratio; HADS = Hospital Anxiety Depression Scale; BDI = Beck Depression Inventory.
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trophy and not fat. Therefore, the use of BMI may not re-
flect a simple increase in total fat, and this finding may be
an important confounding bias in several studies that
fail to find correlations between BMI and psychiatric
disorders [21,22].
Unfortunately, our study was not powered to deter-
mine a causal relationship between lean mass and anx-
iety/depressive symptoms in overweight individuals with
MS. We may, however, raise the hypothesis that an in-
crease in lean mass may indicate a healthier individual
and therefore be a protective factor for depressive and
anxiety symptoms. This hypothesis has already been par-
tially supported by findings of Wagner et al. [23] and
Wallymahmed et al. [24] in different populations, and
recently by Gubata et al. [21] in a young population. In
contrast, one may also speculate that patients with a bet-
ter psychological profile (i.e., lower rates of psychiatric
symptoms) may be more prone to physical activity,
which would lead to a significant increase in muscle
mass. Lastly, an inverse situation also seems plausible. It
has already been demonstrated that older patients with
reduced lean mass (sarcopenia) may present an in-
creased prevalence of depressive symptoms [25]. Similar
results were obtained by Kress et al. [26], who have dem-
onstrated that underweight men in the U.S. military ac-
tive service had increased odds of depressive symptoms.
It seems reasonable to speculate that in this population,
underweight men would indicate men with diminished
lean mass.
Our study has a few limitations. First of all, only a
small number of overweight and obese patients with MS
were evaluated. This is a very selective population and fur-
ther studies are necessary to confirm whether our findings
would also be applicable for different populations (e.g. leanindividuals, obese individuals without MS, morbidly
obese patients). Second, as only 10 individuals were male,
we could not determine the impact of gender in the
relationship between body composition and psychiatric
symptoms. Third, Prodigy densitometer does not distinct
between subcutaneous and visceral fat, which might have
allowed for a more thorough analysis of the role of each
type of fat in the present study. Finally, physical activity
might be an important confounding variable in the rela-
tionship between body composition and psychiatric symp-
toms. Although we did not include a specific instrument
to measure physical activity, this information was obtained
in the initial evaluation. None of the participants was
practicing regular physical activity in the 6 months prior
to study enrollment. Therefore, we may speculate that
physical activity may not be an important determinant of
our findings.Conclusion
In conclusion, in overweight and obese individuals with
MS, psychological status were directly correlated with
total body and regional fat, and inversely related to lean
mass. Taken together, these results suggest that the rela-
tionship between psychiatric symptoms and body weight
should be carefully interpreted when only anthropomet-
ric variables are considered, especially if these variables
are unable to differentiate lean from fat mass. Further
and prospective studies are necessary to clarify the im-
pact that increased lean mass, especially if associated
with physical activity, would have in the psychopatho-
logical profile of larger populations.Competing interests
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